Articles

GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes

Marx N, Husain M, Lehrke M, et al.

First published: December 12, 2022  DOI: 10.1161/CIRCULATIONAHA.122.059595